Braze, Inc. Files 8-K on Financials and Officer Changes

TL;DR

Braze dropped an 8-K: financials updated, some execs out, new directors in. Check it.

AI Summary

Braze, Inc. filed an 8-K on February 3, 2025, reporting on its results of operations and financial condition as of February 1, 2025. The filing also disclosed the departure of certain officers, the election of directors, and compensatory arrangements. Additionally, it included information on Regulation FD disclosures and financial statements and exhibits.

Why It Matters

This filing provides investors with crucial updates on Braze's financial performance and significant corporate governance changes, impacting the company's strategic direction and leadership.

Risk Assessment

Risk Level: medium — The filing involves financial results and changes in corporate officers and directors, which can indicate shifts in company strategy or performance.

Key Players & Entities

• Braze, Inc. (company) — Registrant
• Appboy, Inc. (company) — Former company name
• 001-41065 (company) — SEC File Number
• 452505271 (company) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $0.0001 — stered Class A common stock, par value $0.0001 per share BRZE The Nasdaq Stock Market
• $17,000 — ed to receive (i) cash consideration of $17,000, and (ii) the continued vesting of his

Filing Documents

• brz-20250201.htm (8-K) — 30KB
• exhibit101-transitionsepar.htm (EX-10.1) — 137KB
• exhibit991-pressrelease.htm (EX-99.1) — 8KB
• 0001676238-25-000015.txt ( ) — 336KB
• brz-20250201.xsd (EX-101.SCH) — 2KB
• brz-20250201_lab.xml (EX-101.LAB) — 23KB
• brz-20250201_pre.xml (EX-101.PRE) — 13KB
• brz-20250201_htm.xml (XML) — 3KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. The information contained in Section 7.01 of this Current Report on Form 8-K is incorporated herein by reference. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1, 2025, Myles Kleeger informed Braze, Inc. (the "Company") of his intention to resign as President and Chief Commercial Officer of the Company, effective June 1, 2025 (the "Termination Date"). Thereafter, Mr. Kleeger has agreed to provide advisory services to the Company as a consultant until November 30, 2025. On February 1, 2025, the Company entered into a transition, separation and release agreement with Mr. Kleeger (the "Transition Agreement") in connection with his anticipated resignation. The Transition Agreement provides that Mr. Kleeger's employment with the Company will terminate on the Termination Date, and that between February 1, 2025 and June 1, 2025 (the "Transition Period"), Mr. Kleeger will remain employed by the Company on a full-time basis as the President and Chief Commercial Officer and carry out such duties and responsibilities as requested by the Company's Chief Executive Officer, including transitioning Mr. Kleeger's duties and responsibilities to his successor. During the Transition Period, Mr. Kleeger will continue to receive his base salary and will remain eligible to participate in the Company's compensation and employee benefit plans as they are made available to employees of the Company, including continued vesting of Mr. Kleeger's stock options and restricted stock units; provided, that if Mr. Kleeger's service under the Transition Agreement were to terminate due to his death or disability, then the portion of Mr. Kleeger's stock options and restricted stock units that would have otherwise vested on or prior to November 30, 2025 will be accelerated to vest as of the date of Mr. Kleeger's deat

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On February 3, 2025, the Company issued a press release announcing the Company's leadership change described herein and other updates regarding the Company's go-to-market and sales organizations. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference. *** The information contained in Items 2.02 and 7.01 and the accompanying Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Transition, Separation and Release Agreement between Braze, Inc. and Myles Kleeger, dated February 1, 2025 99.1 Press Release of Braze, Inc., dated February 3, 2025 104 Cover Page Interactive Data (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRAZE, INC. By: /s/Susan Wiseman Susan Wiseman General Counsel Dated: February 3, 2025

View Full Filing

View this 8-K filing on SEC EDGAR